Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
Author(s) -
Helen Cox,
Johnny Daniels,
Odelia Muller,
Mark P. Nicol,
Vivian Cox,
Gilles Van Cutsem,
Sizulu Moyo,
Virginia De Azevedo,
Jennifer Hughes
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv014
Subject(s) - medicine , interquartile range , tuberculosis , context (archaeology) , rifampicin , mycobacterium tuberculosis , genexpert mtb/rif , pathology , paleontology , biology
Decentralization of treatment for rifampicin-resistant tuberculosis was associated with high treatment initiation and resulted in reduced time to treatment initiation. Xpert for TB diagnosis resulted in a significant further reduction in time to treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom